Evidence map›Paper›PMID 41908396›Full record

ArticleACS omega2026

Short Antimicrobial Peptides Based on Arginine and Tryptophan: Agents with Potential in Combating Resistant Pathogens.

Eric Fernández de la Cruz, Jessica T Mhlongo, Ashish Kumar, Fernando Albericio, Miguel Viñas, Paula Espinal, Ester Fusté, Beatriz G de la Torre

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eric Fernández de la CruzLaboratory of Molecular Microbiology & Antimicrobials, Department of Pathology and Experimental Therapeutics, Faculty of Medicine & Health Sciences, IDIBELL-University of Barcelona, Campus Bellvitge, L'Hospitalet de Llobregat, Barcelona 08907, Spain.
Jessica T MhlongoMedical School, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal 4041, South Africa.
Ashish KumarMedical School, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal 4041, South Africa.
Fernando AlbericioPeptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban, KwaZulu-Natal 4001, South Africa.ORCID https://orcid.org/0000-0002-8946-0462
Miguel ViñasLaboratory of Molecular Microbiology & Antimicrobials, Department of Pathology and Experimental Therapeutics, Faculty of Medicine & Health Sciences, IDIBELL-University of Barcelona, Campus Bellvitge, L'Hospitalet de Llobregat, Barcelona 08907, Spain.
Paula EspinalLaboratory of Molecular Microbiology & Antimicrobials, Department of Pathology and Experimental Therapeutics, Faculty of Medicine & Health Sciences, IDIBELL-University of Barcelona, Campus Bellvitge, L'Hospitalet de Llobregat, Barcelona 08907, Spain.
Ester FustéLaboratory of Molecular Microbiology & Antimicrobials, Department of Pathology and Experimental Therapeutics, Faculty of Medicine & Health Sciences, IDIBELL-University of Barcelona, Campus Bellvitge, L'Hospitalet de Llobregat, Barcelona 08907, Spain.
Beatriz G de la TorreMedical School, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal 4041, South Africa.ORCID https://orcid.org/0000-0001-8521-9172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limitations of conventional antibiotics due to the rise of antimicrobial resistance demand new therapeutic strategies. Antimicrobial peptides represent a promising alternative because of their broad-spectrum activity and low propensity for inducing resistance. In this study, we designed and evaluated a set of seven-residue Arg/Trp-based peptides. All peptides were successfully synthesized and characterized, and their activities were assessed against

Identifiers

PMID41908396
PMCPMC13019373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.